Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.
about
Cholesterol homeostasis: a key to prevent or slow down neurodegenerationInvestigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic reviewAssociation between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?Curcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In VitroPsychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatmentAcute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat.Antipsychotic-induced increase in lipid biosynthesis: activation through inhibition?Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitroInfluence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cellsα-Linolenic acid suppresses cholesterol and triacylglycerol biosynthesis pathway by suppressing SREBP-2, SREBP-1a and -1c expression.The systematic analysis of coding and long non-coding RNAs in the sub-chronic and chronic stages of spinal cord injury.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease.Necroptosis-like Neuronal Cell Death Caused by Cellular Cholesterol Accumulation.Bioinformatic analyses and conceptual synthesis of evidence linking ZNF804A to risk for schizophrenia and bipolar disorder.A meta-analysis of caloric restriction gene expression profiles to infer common signatures and regulatory mechanisms.Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish.Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in VitroPolymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.Upstream genetic variant near INSIG2, influences response to carnitine supplementation in bipolar patients with valproate-induced weight gain.Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.Drug Repositioning in Glioblastoma: A Pathway Perspective.Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.
P2860
Q21129248-B1E50115-0F02-4D6D-81D7-5E8D4AF71211Q28078252-E53A88BE-C716-4740-AB70-76616E7C858CQ28264722-E86F1CB0-0802-4A19-B4DC-B448A95A8C75Q28550570-2FDED7DA-A2C8-4455-B51D-2766498291E3Q33498169-AB1EEAC1-A7C7-4900-8BCB-FA2ED7967DD3Q34405264-8DE3B678-8460-4147-A6DD-C1C3AFCBB208Q34506022-06377132-EE5B-4E17-938B-AD5A5C16AD38Q35675775-F03344B6-3017-40C6-84DA-6D1CB10B73E0Q36658336-7C534234-BA34-4227-B18B-012D51436D56Q36658341-7B4446DD-9A9E-46B4-862D-ABD4713CE481Q37194960-B22D254D-2751-44A1-84FD-8076C260FA3CQ37369567-9D2A09A5-ABDE-4587-98B5-CCEFB8BE4E53Q37595312-F54F56AF-FC21-430B-B7F2-E7FFB0C3827FQ37865505-CB790510-B588-46DE-B0D4-BFCA2A0E1C42Q37926893-C687EB9B-CAD4-4562-9D46-F329AFA238E5Q38194900-E17F1C76-6527-4A0B-BACC-549F220951A1Q38290575-51F6B7CE-1D85-4203-A461-2BF296998468Q38293348-202A2797-E074-40D7-A6C2-CE0B1E4B237BQ38327781-CD4F9D5A-61A8-41B7-8751-C0CCE6520ED9Q38444377-F12C11C8-6E54-49CB-B2F9-1D01440126A1Q38927030-5D7BDF4C-A94D-451C-92F9-53F1E8089734Q39671646-5B0092FA-0B76-4E21-8A3E-EA5A105461ABQ46308032-4F77C0F3-EC36-4940-B73F-9F5FC6E54538Q47182175-ACBFA849-08B6-494A-A552-6F79A4EDED51Q47332928-A7205D22-12ED-45E7-ADCC-A0E9822B7E7DQ47359953-BCBC3BF6-F2E6-436B-B70C-07C02804E00EQ50527728-C1EEB312-ABFA-4776-86D8-798F6773D7EBQ51972946-22383908-52F8-47B9-886D-5EABE40007ADQ52608766-868AB243-E768-4B83-9E44-5C826FCCA461Q53511661-17D7FFB9-C140-4C3E-A5CD-7A674B960215
P2860
Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@ast
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@en
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@nl
type
label
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@ast
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@en
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@nl
prefLabel
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@ast
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@en
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@nl
P2093
P2860
P356
P1433
P1476
Drug-induced activation of SRE ...... n various antipsychotic drugs.
@en
P2093
Bjarte Håvik
Johan Fernø
Silje Skrede
Vidar M Steen
P2860
P2888
P356
10.1186/1471-2202-7-69
P577
2006-10-20T00:00:00Z
P5875
P6179
1028913670